These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16814670)

  • 1. Moving preconditioning from bench to bedside.
    Kloner RA
    J Am Coll Cardiol; 2006 Jul; 48(1):215-6. PubMed ID: 16814670
    [No Abstract]   [Full Text] [Related]  

  • 2. Post-reperfusion myocardial infarction: long-term survival improvement using adenosine regulation with acadesine.
    Mangano DT; Miao Y; Tudor IC; Dietzel C; ;
    J Am Coll Cardiol; 2006 Jul; 48(1):206-14. PubMed ID: 16814669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acadesine: a unique cardioprotective agent for myocardial ischemia.
    Nawarskas JJ
    Heart Dis; 1999; 1(4):255-60. PubMed ID: 11720632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of acadesine in clinical myocardial protection.
    Alkhulaifi AM; Pugsley WB
    Br Heart J; 1995 Apr; 73(4):304-5. PubMed ID: 7756061
    [No Abstract]   [Full Text] [Related]  

  • 5. Acadesine: the prototype adenosine regulating agent for reducing myocardial ischaemic injury.
    Mullane K
    Cardiovasc Res; 1993 Jan; 27(1):43-7. PubMed ID: 8458030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine and myocardial protection.
    Gatell JA; Barner HB; Shevde K
    J Cardiothorac Vasc Anesth; 1993 Aug; 7(4):466-80. PubMed ID: 8400105
    [No Abstract]   [Full Text] [Related]  

  • 7. Acadesine, an adenosine-regulating agent with the potential for widespread indications.
    Drew BG; Kingwell BA
    Expert Opin Pharmacother; 2008 Aug; 9(12):2137-44. PubMed ID: 18671468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].
    Lupi Herrera E; Gaspar J; González Pacheco H; Martínez Sánchez C; Pastelín Hernández G; Luna Ortiz P; Chávez Cosio E
    Arch Cardiol Mex; 2006; 76 Suppl 4():S76-101. PubMed ID: 17469337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine and K(+)-induced Ca2+ loading.
    Cheng TO
    Ann Thorac Surg; 1997 Aug; 64(2):588-9. PubMed ID: 9262636
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of acadesine on myocardial infarction, stroke, and death following surgery. A meta-analysis of the 5 international randomized trials. The Multicenter Study of Perioperative Ischemia (McSPI) Research Group.
    Mangano DT
    JAMA; 1997 Jan 22-29; 277(4):325-32. PubMed ID: 9002496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside increases myocardial glucose uptake during reperfusion and induces late pre-conditioning: potential role of AMP-activated protein kinase.
    Kristiansen SB; Solskov L; Jessen N; Løfgren B; Schmitz O; Nielsen-Kudsk JE; Nielsen TT; Bøtker HE; Lund S
    Basic Clin Pharmacol Toxicol; 2009 Jul; 105(1):10-6. PubMed ID: 19486332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of acadesine on the incidence of myocardial infarction and adverse cardiac outcomes after coronary artery bypass graft surgery. Multicenter Study of Perioperative Ischemia (McSPI) Research Group.
    Anesthesiology; 1995 Oct; 83(4):658-73. PubMed ID: 7574044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine pretreatment of human myocardium and ischemic preconditioning.
    Lee HT
    Circulation; 1998 Jun; 97(22):2279. PubMed ID: 9631881
    [No Abstract]   [Full Text] [Related]  

  • 14. AMP-activated protein kinase: the guardian of cardiac energy status.
    Hardie DG
    J Clin Invest; 2004 Aug; 114(4):465-8. PubMed ID: 15314681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward a better understanding of the metabolic effects of ischemic preconditioning in humans.
    Dawn B; Bolli R
    J Cardiothorac Vasc Anesth; 2001 Aug; 15(4):409-11. PubMed ID: 11505340
    [No Abstract]   [Full Text] [Related]  

  • 17. The emerging application of remote ischemic conditioning in the clinical arena.
    Yetgin T; Manintveld OC; Groen F; Tas B; Kappetein AP; van Geuns RJ; Zijlstra F; Duncker DJ
    Cardiol Rev; 2012; 20(6):279-87. PubMed ID: 22858831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ischemic postconditioning: an effective strategy of myocardial protection?].
    Rastaldo R; Penna C; Cappello S; Mancardi D; Pagliaro P; Losano G
    G Ital Cardiol (Rome); 2006 Jul; 7(7):464-73. PubMed ID: 16977786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential of pre and post conditioning to prevent cardiac ischemic sequelae.
    Meijer RC; Kappetein AP; Serruys PW; Bogers JJ
    Wien Klin Wochenschr; 2007; 119(11-12 Suppl 1):21-3. PubMed ID: 19618594
    [No Abstract]   [Full Text] [Related]  

  • 20. Harnessing nature's own cardiac defense mechanism with acadesine, an adenosine regulating agent: importance of the endothelium.
    Engler RL
    J Card Surg; 1994 May; 9(3 Suppl):482-92. PubMed ID: 8069041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.